Patrik Buzgau

Mr. Patrik Buzgau

orcid
Medicine Undergraduate Student @ UMFST GEP Targu Mures, Roma...

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Patrik BuzgauPatrik Buzgau
Patrik Buzgau
MSMark Slevin
Mark Slevin
IBIoana Theodora Barna
Ioana Theodora Barna
LDLóránd Dénes
Lóránd Dénes
AVAmelia Tero Vescan
Amelia Tero Vescan
YPYlenia Pastorello
Ylenia Pastorello
C-reactive protein (CRP) has emerged as a crucial link between systemic and neuroinflammatory processes, though its role across neurological autoimmune disorders remains incompletely understood. Pathologies such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), Guillain–Barré syndrome (GBS), and myasthenia gravis (MG) share chronic, dysregulated inflammation resulting from loss of immune tolerance. Their pathogenesis arises from interactions among genetic susceptibility, environmental factors, and gut microbiota alterations that trigger autoreactive immune cascades through molecular mimicry, ectopic antigen expression, or paraneoplastic cross-reactivity. These immune pathways sustain inflammation and promote neuroaxonal injury. CRP, synthesized mainly by hepatocytes in response to interleukin-6 (IL-6), functions as both an effector and reporter of inflammation, linking systemic immune activation to neuroinflammatory damage. Elevated CRP levels correlate with unfavorable outcomes, including accelerated disability in MS, IL-6-mediated astrocyte injury in NMOSD, respiratory failure in GBS, and crisis susceptibility in MG. Composite indices such as the CRP-to-albumin ratio are emerging as refined prognostic markers, though interpretation is limited by non-specificity and biological variability. This review integrates current evidence on CRP’s mechanistic roles, clinical associations, and translational potential in neuroinflammatory disorders, combining molecular, clinical, and imaging perspectives to refine its role within inflammation-driven neurodegeneration.

21 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Patrik BuzgauPatrik Buzgau
Patrik Buzgau
EAEmil Marian Arbanasi
Emil Marian Arbanasi
CCConstantin Claudiu Ciucanu
Constantin Claudiu Ciucanu
RKRéka Kaller
Réka Kaller
EAEliza Mihaela Arbănași
Eliza Mihaela Arbănași
Gian Luca GraziGian Luca Grazi
Gian Luca Grazi
Background: Vascular leiomyosarcoma (LMS) is an exceptionally rare and aggressive soft tissue sarcoma arising from the smooth muscle cells of the vascular wall. They account for approximately 0.5–2% of adult soft-tissue sarcomas and are the most frequent primary malignancy of vascular origin. Among venous sites, the inferior vena cava (IVC) is the most frequently involved, accounting for more than half of reported vascular LMS cases, with rarer occurrences in peripheral veins, including the internal saphenous vein and the external iliac vein. Case Presentation: We report a case series comprising two distinct presentations of vascular LMS involving the internal saphenous vein and the inferior vena cava, respectively. Each case highlights unique clinical manifestations, radiologic features, histopathologic diagnosis, and therapeutic challenges inherent to the involved vascular territory. Surgical resection with clear margins was the primary treatment modality, complemented by adjuvant therapies tailored according to tumor grade and extent. Literature Review: An updated literature review contextualizes these findings, detailing epidemiology, diagnostic challenges, prognostic factors, and current management approaches. It emphasizes the rarity of leiomyosarcomas originating from major venous pathways and highlights variability in clinical presentation, tumor size, growth patterns, and outcomes. Achieving complete surgical removal with negative margins continues to be the primary treatment goal and the most significant prognostic factor. Conclusions: Given the paucity of cases, our series contributes valuable insights into the clinical spectrum and multidisciplinary approach necessary for optimal outcomes in vascular LMS. Early recognition and aggressive treatment remain paramount to improving survival in this rare malignancy.

16 April 2026 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
EREliza Russu
Eliza Russu
Patrik BuzgauPatrik Buzgau
Patrik Buzgau
CCConstantin Claudiu Ciucanu
Constantin Claudiu Ciucanu
AMAlexandru MureșAn
Alexandru MureșAn
RSRăzvan Cătălin Son
Răzvan Cătălin Son
EAEmil-Marian ArbănașI
Emil-Marian ArbănașI
Introduction: Abdominal aortic aneurysms (AAA) are a potentially fatal vascular condition defined by an aortic diameter exceeding 3.0 cm or demonstrating a ≥50% increase in the normal diameter. This study aims to evaluate the impact of preoperative nutritional status on rupture at presentation and early postoperative complications. Methods: This retrospective, monocentric, observational study included 125 AAA patients admitted for open surgical repair (OSR). Demographic data, comorbidities, and risk factors were obtained from the hospital’s electronic database. Nutritional status was quantified using albumin, total protein, Prognostic Nutritional Index (PNI), and CONUT Score. Primary outcomes were postoperative AKI and 30-day mortality. Results: The average age was 72.6 ± 7.5 years, with 83.2% of patients being male. Rupture at presentation occurred in 56.0%, AKI in 20.0%, and the 30-day mortality rate was 47.2%. Patients with poor outcomes had lower levels of albumin, total protein, and PNI, and higher CONUT Score (all p < 0.05). ROC curve analysis showed that albumin, total protein, and PNI had strong correlations with rupture and 30-day mortality, with AUC values of approximately 0.82–0.98, whereas CONUT Score demonstrated a moderate association. In multivariate analyses, lower albumin, serum total protein, and PNI remained independently associated with rupture and 30-day mortality. Meanwhile, a higher CONUT Score remained independently associated with rupture but not with 30-day mortality after full adjustment. Conclusion: Poor preoperative nutritional status is strongly associated with aneurysm rupture at presentation and increased 30-day mortality after OSR. However, in ruptured cases, these biomarkers may reflect acute hemorrhage and physiological stress rather than baseline nutritional status alone.